3 Broker Favorite Biopharmas Your Portfolio Must Have Post author:Sam Post published:January 17, 2018 Post category:BioPharma These stocks have been given a Strong Buy or Buy rating by 80% or more brokers. Source: BioSpace You Might Also Like Epizyme Falls as Investors Take in Disappointing Phase II Data June 14, 2017 MediWound Announces Changes To Its Board Of Directors May 17, 2017 This Bay Area Biotech is Being Wooed by Drug Giant Novo Nordisk A/S March 8, 2017
